CLOs on the Move

Beverly Hospital

www.beverly.org

 
Beverly Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Montebello, CA. To find more information about Beverly Hospital, please visit www.beverly.org
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.beverly.org
  • 309 W Beverly Blvd
    Montebello, CA USA 90640-4308
  • Phone: 323.726.1222

Executives

Name Title Contact Details

Similar Companies

Central Georgia Health Network

CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.

Awair

Our mission at Awair is to empower you with the knowledge, motivation, and confidence to be healthy and thrive in your environment.

Colorado Health Care Association

Colorado Health Care Association is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blooma

Blooma nourishes the mind, body and spirit of moms-to-be, new mamas and their families through yoga, barre and childbirth education classes.

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.